How to Invest in the Future of Vaccines, From Big Pharma to ETFs

When investors try to identify the next exciting frontier for mankind, they may think of conquering outer space. But there’s a more vital one here on earth.

The vaccine industry and the vast ecosystem surrounding it had areas of rapid growth before the pandemic, with developments such as the approval of a new shingles vaccine by the U.S. Food and Drug Administration.

But the sector has exploded as companies race to develop Covid-19 vaccinations, treatments, booster shots and more. Some 299 vaccine candidates are listed on the World Health Organization’s Covid-19 vaccine tracker, with 114 in some phase of of clinical development and the other 185 in earlier stages. Emerging technologies such as the use of ...